UNODC and Republican Center for Mental Health of Kazakhstan join efforts to ensure the continuity and sustainability of drug dependence...
The company’s exhibition stand will showcase its portfolio. Credit: rafapress via Shutterstock.
An article by The Wall Street Journal, “中国降低医疗成本的独特行动:大规模医药反腐 ” reported on China’s sweeping anti-corruption campaign launched across hospitals and medical...
Vygon is a leading French medical device company with key expertise in critical care, neonatology and vascular access Vygon India...
New Delhi: Hypertension is a driving force in the global epidemic of Non-Communicable Diseases (NCDs) and the leading risk factor...
MedCare Telehealth Powered by Zoom, through the Zoom Technology Platform, comprehensively covers disease management, consultations, and beneficial information exchange for...
The recent “Asia Pacific Healthcare Augmented Reality and Virtual Reality Market” : Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024 to...
Family doctors, often known as general practitioners, play a central role in improving population health and delivering personal, comprehensive, and...
By Dr Poonam Khetrapal Singh, WHO Regional Director for South-East AsiaAccess to quality healthcare is a fundamental human right, yet...
泰诺麦博登上2024年VBEF双榜单,斯泰度塔单抗注射液获“创新力产品”称号 近日,第八届未来医疗生态展会在北京举行。会上,2024年未来医疗100强榜单正式揭晓。珠海泰诺麦博制药股份有限公司(以下简称“泰诺麦博”)凭借其在医疗健康领域展现出的创新力和行业贡献,登上“中国创新医药与生物制品榜TOP100”。与此同时由泰诺麦博自主研发的斯泰度塔单抗注射液在众多产品中脱颖而出,登上
Asiana Network™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC